Tbit™ Blood Testing Platform

Nano Technology

The breakthrough science integrated into the Tbit™ blood testing platform is based upon the revolutionary work of Nanosys, Inc., a pioneer of nanoscale technology. The unique design includes an array of ultrasensitive nanowires. BioDirection has developed a proprietary process that functionalizes the nanowires, allowing them to detect and measure specific protein molecules released by the brain immediately after a concussion. The unique size and electrical properties of the nanowires allow for single molecule capture never before available in a simple point-of-care device.